Error: Could not add to watchlist. X
+ Watchlist

Intercell AG

ICLL:AV
Acquired
ICLL:AV was acquired by VLA:FP
EUR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-0.49
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Intercell AG is a biotechnology company that develops vaccines for the prevention and treatment of infectious diseases. The Company has developed a vaccine to protect travelers from Japanese encephalitis.
Address
Campus Vienna Biocenter 3
Vienna, 1030
Austria
Phone
43-1-20620